The interplay between hormonal dynamics, particularly elevated progesterone levels in BRCA1 mutation carriers, the RANK/RANKL signaling pathway, and ELF5 may provide a crucial mechanistic link to the increased breast cancer risk observed in these individuals. This evidence concerns the gene TNFRSF11A and breast carcinoma.